Latest FDA Stories
BUFFALO GROVE, Ill., Feb.
- Decision could speed access to LCZ696 for heart failure with reduced ejection fraction patients in the US, reducing total review time from 12 to 8 months(1) EAST HANOVER, N.J., Feb.
WOODCLIFF LAKE, N.J., Feb.
Patients Can Now Be Removed from Respiratory Isolation Following One or Two Negative Xpert MTB/RIF Results SUNNYVALE, Calif., Feb.
Fragile facial skin is one of the first areas of the body to show signs of aging, and until now traditional cellular regeneration products have offered little, if any visible changes in skin vitality.
Morcellator lawsuits filed on behalf of women who allegedly experienced the spread of uterine sarcoma and other malignancies have been mounting in U.S.
New dose approved by FDA for the prevention of postmenopausal osteoporosis only; higher doses of Minivelle can also treat moderate to severe hot flashes due to menopause MIAMI and
Inspired by her husband’s story and to help others, Victoria Bliss-Calkins opens Oxygen Oasis Hyperbaric Wellness Center to treat both FDA approved and Internationally treated conditions.
The FDA has decided that it will not regulate a class of low-risk products it calls general wellness products.
FDA's Orange Book Updated to Reflect New Vogelxo(TM) Rating MAPLE GROVE, Minn., Feb.
- A political dynamiter.